Literature DB >> 4528709

Regulation of newly synthesized acetylcholinesterase in muscle cultures treated with diisopropylfluorophosphate.

B W Wilson, C R Walker.   

Abstract

Brief treatment with 0.1 mM diisopropylfluorophosphate inhibited an average of 89% of the acetylcholinesterase (EC 3.1.1.7; acetylcholine hydrolase) activity of cultures of chick embryo muscle. As long as protein synthesis occurred, an average of 78% of the activity returned within 4 hr. Newly synthesized acetylcholinesterase did not stain cytochemically, was rapidly and extensively degraded or released in the presence of 10 muM cycloheximide, and consisted mainly of low-molecular-weight forms. Acetylcholinesterase activity first appeared around the nucleus, about 4 hr after treatment with diisopropylfluorophosphate, and then spread to the rest of the cell about the time release of acetylcholinesterase was detected in the medium. With time, more and more of the enzyme was retained in the cells after treatment with cycloheximide, and the proportions of low-molecular-weight forms decreased and high-molecular-weight forms increased. The results suggest that newly synthesized acetylcholinesterase undergoes an orderly process of binding, movement, and assembly in diisopropylfluorophosphate treated, and probably also in untreated, embryo muscle fibers.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4528709      PMCID: PMC388649          DOI: 10.1073/pnas.71.8.3194

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Denervation effects on the presumed de novo synthesis of muscle cholinesterase and the effects of acetylcholine availability on retinal cholinesterase.

Authors:  S Rose; P H Glow
Journal:  Exp Neurol       Date:  1967-07       Impact factor: 5.330

2.  Inhibition of cholinesterases of rat diaphragm muscle by organophosphates and spontaneous recovery of enzyme activity in vitro.

Authors:  F Welsch; W D Dettbarn
Journal:  Biochem Pharmacol       Date:  1972-04-01       Impact factor: 5.858

3.  Acetylcholinesterases and non-specific esterases in developing avian tissues: distribution and molecular weights of esterases in normal and dystrophic embryos and chicks.

Authors:  B W Wilson; M A Mettler; R V Asmundson
Journal:  J Exp Zool       Date:  1969-09

4.  Acetylcholinesterase activity in the chick embryo spinal cords.

Authors:  M M Turbow; A Burkhalter
Journal:  Dev Biol       Date:  1968-02       Impact factor: 3.582

5.  Metabolic behavior of isozymes of acetylcholinesterase.

Authors:  G A Davis; B W Agranoff
Journal:  Nature       Date:  1968-10-19       Impact factor: 49.962

6.  Innervation and the regulation of acetylcholinesterase activity during the development of normal and dystrophic chick muscle.

Authors:  B W Wilson; M A Kaplan; W C Merhoff; S S Mori
Journal:  J Exp Zool       Date:  1970-05

7.  The development of neuro-muscular correlations, in vertebrates.

Authors:  G Filogamo; G Gabella
Journal:  Arch Biol (Liege)       Date:  1967

8.  Cholinesterase behaviour in the denervated and reinnervated muscles.

Authors:  G Filogamo; G Gabella
Journal:  Acta Anat (Basel)       Date:  1966

9.  A kinetic analysis of myogenesis in vitro.

Authors:  M C O'Neill; F E Stockdale
Journal:  J Cell Biol       Date:  1972-01       Impact factor: 10.539

10.  The appearance of acetylcholinesterase in the myotome of the embryonic rabbit. An electron microscope cytochemical and biochemical study.

Authors:  V M Tennyson; M Brzin; P Slotwiner
Journal:  J Cell Biol       Date:  1971-12       Impact factor: 10.539

View more
  10 in total

1.  Mathematical model to predict skin concentration of drugs: toward utilization of silicone membrane to predict skin concentration of drugs as an animal testing alternative.

Authors:  Kenji Sugibayashi; Hiroaki Todo; Takeshi Oshizaka; Yoko Owada
Journal:  Pharm Res       Date:  2009-11-11       Impact factor: 4.200

2.  Analysis of simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin.

Authors:  K Sugibayashi; T Hayashi; T Hatanaka; M Ogihara; Y Morimoto
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

3.  De novo amplification within a "silent" human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides.

Authors:  C A Prody; P Dreyfus; R Zamir; H Zakut; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Asymmetric acetylcholinesterase is assembled in the Golgi apparatus.

Authors:  R L Rotundo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

Review 5.  Biogenesis, assembly and trafficking of acetylcholinesterase.

Authors:  Richard L Rotundo
Journal:  J Neurochem       Date:  2017-03-21       Impact factor: 5.372

6.  Biosynthesis and secretion of catalytically active acetylcholinesterase in Xenopus oocytes microinjected with mRNA from rat brain and from Torpedo electric organ.

Authors:  H Soreq; R Parvari; I Silman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Brain parenchymal metabolism of 5-iodo-2'-deoxyuridine and 5'-ester prodrugs.

Authors:  M K Ghosh; A K Mitra
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

8.  Safe disposal of diisopropyl fluorophosphate (DFP).

Authors:  G Lunn; E B Sansone
Journal:  Appl Biochem Biotechnol       Date:  1994-11       Impact factor: 2.926

9.  Expression of cholinesterase gene(s) in human brain tissues: translational evidence for multiple mRNA species.

Authors:  H Soreq; D Zevin-Sonkin; N Razon
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

10.  Properties of growth-related acetylcholinesterase in a cell line of fibroblastic origin.

Authors:  E M Bartos; A D Glinos
Journal:  J Cell Biol       Date:  1976-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.